Lexington, KY – September 9, 2013.
Omega Ophthalmics LLC (Omega) has announced today that Eric D. Donnenfeld, MD, FACS has joined their Medical Advisory Board, effective immediately.
Eric Donnenfeld, MD, is a founding partner of Ophthalmic Consultants of Long Island and Connecticut. He graduated magna cum laude from Dartmouth College in 1977 and first in his class at Dartmouth Medical School in 1980. He was a resident and Chief Resident at Manhattan Eye, Ear and Throat Hospital and he completed a Cornea Fellowship at Wills Eye Hospital in 1985. He is a trustee of Dartmouth Medical School and a clinical professor of ophthalmology at NYU.
“To have Dr. Donnenfeld join Drs. Lindstrom and Slade as our first Medical Advisory Board members is a true honor and privilege,” stated Dr. Gary Wörtz, Omega’s Chief Medical Officer. “We look forward to tapping into Dr. Donnenfeld’s vast expertise as we continue to develop our technology.”
Dr. Donnenfeld has served as Resident Instructor at Manhattan Eye, Ear and Throat Hospital and as Program Director at North Shore University Hospital. He is a National Medical Director of TLC and Surgical Director of the Lions Eye Bank for Long Island. Dr. Donnenfeld served as president of many professional societies including the Nassau Surgical Society, cornea section of ASCRS, the Ophthalmology Division of the Nassau Academy of Medicine, and the International Ocular Microbiology and Immunology Group. He is the current president of ASCRS. Dr. Donnenfeld is the editor in chief of Cataract and Refractive Surgery Today.
ABOUT OMEGA OPHTHALMICS
Omega Ophthalmics is a medical device company making significant advancements in the global ophthalmology industry through its patent-pending, proprietary technologies for intraocular lenses, capsular bags, and high technology applications within the eye. Founded by Gary Wörtz, MD and Rick Ifland, Omega is headquartered in Lexington, KY.
For more information about Omega Ophthalmics, contact Rick Ifland, CEO.
For more information about Omega’s technology, contact Gary Wörtz, MD, CMO.